Bruker (BRKR) Competitors

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends.

Does the media prefer WAT or BRKR?

In the previous week, Waters had 50 more articles in the media than Bruker. MarketBeat recorded 65 mentions for Waters and 15 mentions for Bruker. Bruker's average media sentiment score of 1.08 beat Waters' score of 0.58 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	24 Very Positive mention(s)	5 Positive mention(s)	27 Neutral mention(s)	6 Negative mention(s)	3 Very Negative mention(s)	Positive
Bruker	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation and earnings, WAT or BRKR?

Waters has higher earnings, but lower revenue than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$2.98B	6.96	$637.83M	$11.02	31.66
Bruker	$3.45B	1.60	$113.10M	$0.52	70.12

Which has more risk & volatility, WAT or BRKR?

Waters has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

Is WAT or BRKR more profitable?

Waters has a net margin of 21.56% compared to Bruker's net margin of 3.36%. Waters' return on equity of 46.31% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	21.56%	46.31%	15.67%
Bruker	3.36%	21.01%	6.46%

Do analysts prefer WAT or BRKR?

Waters currently has a consensus target price of $390.19, suggesting a potential upside of 11.83%. Bruker has a consensus target price of $59.10, suggesting a potential upside of 62.10%. Given Bruker's higher possible upside, analysts plainly believe Bruker is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.61
Bruker	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

Do institutionals & insiders believe in WAT or BRKR?

94.0% of Waters shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.8% of Waters shares are held by company insiders. Comparatively, 27.3% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer WAT or BRKR?

Bruker received 239 more outperform votes than Waters when rated by MarketBeat users. Likewise, 64.62% of users gave Bruker an outperform vote while only 53.43% of users gave Waters an outperform vote.

Company	Underperform	Outperform
Waters	Outperform Votes 444 53.43%	Underperform Votes 387 46.57%
Bruker	Outperform Votes 683 64.62%	Underperform Votes 374 35.38%

Summary

Waters beats Bruker on 11 of the 19 factors compared between the two stocks.